Affordability and relative economic burden of multiple sclerosis biologics in South America: a cross-country analysis of prices, purchasing power and regulatory access.
Madeira da Silva Oliveira P, de Mello Vianna C M, Gil Lopez A J, Bittencourt Gonzalez Mosegui G
Expert Rev Pharmacoecon Outcomes Res. 2026 Oct 31. PMID: 42965313.Abstract
